Diwakar Bastihalli Tukaramrao

Pennsylvania State University — United States

Medicine · Health Sciences

13h-index618citations43works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(9), Acute Myeloid Leukemia Research(7), Phytochemicals and Antioxidant Activities(3), Chronic Myeloid Leukemia Treatments(3), Histone Deacetylase Inhibitors Research(3)

Publications43 total

Reduction of Harmonics in 3-Phase Squirrel Cage Induction Motor by using VFD Method
International Journal of Advanced Research in Science Communication and Technology·2025Open Access
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
Leukemia·2025· 1 citedOpen Access
Abstract 4167: CK2 inhibition restores IKAROS-mediated metabolic control and induces cell death in acute lymphoblastic leukemia
Cancer Research·2025
Abstract 2727: Histone deacetylase (HDAC1) and IKAROS are critical regulators of histone methylation and epigenomic landscape in T-cell acute lymphoblastic leukemia
Cancer Research·2025
Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
2024
Abstract 2846: Investigation of mechanisms that result in health disparity for Hispanic/Latino patients with B acute lymphoblastic leukemia
Cancer Research·2024
Abstract 3271: The casein kinase 2/IKZF1 axis attenuates ceramide accumulation through up-regulation of acid ceramidase: Implications for use of CK2 inhibitors in high-risk pediatric B-cell acute lymphoid leukemia
Cancer Research·2024
Integrating Optical Genome Mapping and Whole Genome Sequencing in Somatic Structural Variant Detection
Journal of Personalized Medicine·2024· 7 citedOpen Access
Abstract C055: Distinct epigenomic regulation of gene expression in Hispanic/Latino children with high-risk B-cell acute lymphoblastic leukemia
Cancer Epidemiology Biomarkers & Prevention·2023
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells
Cell Reports·2023· 7 citedOpen Access
Abstract 3833: Leonurine derivatives as a potential novel therapeutic approach to acute lymphoblastic leukemias (ALL)
Cancer Research·2023· 2 cited
Abstract 6052: Metabolic consequences of casein kinase 2α inhibition in lymphoid leukemia
Cancer Research·2023
Abstract 2677: ROCK inhibitors synergize with the BCL2 inhibitor venetoclax for treatment of AML
Cancer Research·2023
Signaling pathways and regulation of gene expression in hematopoietic cells
Advances in Biological Regulation·2022· 3 cited
IND-2, a Quinoline Derivative, Inhibits the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress, Apoptosis and Inhibiting Topoisomerase II
Life·2022· 9 citedOpen Access
Model-Based Fault Diagnosis of Synchronous Generator Using Dual Extended Kalman Filter and Empirical Mode Decomposition
Lecture notes in electrical engineering·2022· 1 cited
Regulation of Heterochromatin Landscape in T-Cell Acute Lymphoblastic Leukemia
Blood·2021· 1 cited
DJ4 Targets Rho-associated Protein Kinase Pathway and Attenuates Disease Progression in Pre-clinical Murine Models of Acute Myeloid Leukemia
Blood·2021
DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia
Cancers·2021· 6 citedOpen Access
A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells
Cancers·2021· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Sinisa Dovat(15), Arati Sharma(13), Dhimant Desai(12), K. Sandeep Prabhu(8), Daniel Bogush(8), Joseph Schramm(8), Bing He(8), Amit K. Tiwari(7), Yali Ding(7), Chingakham Ranjit Singh(7), Robert F. Paulson(6), Charyguly Annageldiyev(6), Jeremy A. Hengst(6), Fenghua Qian(5), F Singh(4), Saloni Malla(4), James R. Broach(4), David F. Claxton(4), Melanie Ehudin(4), Dayanidhi Raman(3)